News | March 11, 2025
Emcure partners with Vidya Balan for Arth supplements,
Vidya will spark conversations around less discussed and important aspects of health, including intimate care and sleep issues
Vidya will spark conversations around less discussed and important aspects of health, including intimate care and sleep issues
The study demonstrated equivalent efficacy, safety, immunogenicity, and pharmacokinetics between YESINTEK and the reference product Stelara
YESINTEK is approved for the treatment of Crohn’s disease, ulcerative colitis, plaque psoriasis and psoriatic arthritis
Mehta is an industry veteran with over 25 years of experience in the pharmaceutical industry
Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC) is used to temporarily relieve itchy eyes due to pollen, ragweed, grass, animal hair and dander
Results from the open-label extension study of PHOTON demonstrate patients with diabetic macular edema (DME) randomized to Eylea 8 mg maintained visual and anatomic improvements at the end of three years
Alcaftadine Ophthalmic Solution, 0.25% (OTC) is used to temporarily relieve itchy eyes due to pollen, ragweed, grass, animal hair, and dander
US$ 800 million senior secured notes, the largest high yield debut USD bond issuance from India in the last 10 years
A first-in-class muscarinic agonist for the treatment of schizophrenia in adults
These clinical studies support the interchangeability of adalimumab-fkjp at low-concentration with high-concentration adalimumab and ustekinumab biosimilarity
Subscribe To Our Newsletter & Stay Updated
